I don't think it would be that hard to attract a top tier CEO (rubbing elbows with movers & shakers in retail OTC).
Honestly, how do think they would respond when they see first hand how well this device works at completely healing a severe lvl 1 ankle sprain literally overnight? The a knee sprain or twist.
I think they would want to see it again and again to make sure this wasn't a fluke.
Then I would venture to guess they would be extremely eager to work out an incentive based compensation package as they would see the current people in charge haven't a clue how to market this extremely exciting, game changing way people will heal going forward. This new CEO should also be able to make huge money by taking such a leap.
You know the old phrase; you gotta spend money to make money!
What do you think the FDA is thinking? I have my own opinion, but they have to be scratching their head wondering - what are they waiting for, we've already approved the ankle and the knee device.
Now take that into consideration when discussing the SEC. I'm sure these two agencies talk behind the scenes. Both are probably wondering what they're waiting for.
Just my 2 cents. I cannot believe I still own this stock and that after it was approved in February, we still trade near .006? Honesty this baffles me.
This is the most effective way to heal ankle sprains, knee sprains, burns, road rash, lower back pains from sitting too long when driving long distances, etc.
I can speak first hand as my family uses this on every injury listed above.
